屯門醫院是新界屯門區一所公營地區全科醫院，提供24小時急症服務、第二及第三層專科醫療服務。醫院自1990年代啟用，為屯門區及元朗區近百萬人口提供服務。

During the past decade, Tuen Mun Hospital; Clinical Oncology conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 10 clinical trials were completed, i.e. on average, 111.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tuen Mun Hospital; Clinical Oncology" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Pfizer" with 3 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "Tuen Mun Hospital" with 2 trials sponsored and "Chinese University of Hong Kong" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tuen Mun Hospital; Clinical Oncology" #1 collaborator was "German Breast Group" with 1 trials as a collaborator, "Hong Kong Nasopharyngeal Cancer Study Group Limited" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Tuen Mun Hospital; Clinical Oncology" are "Breast Cancer" (6 trials), "Advanced Breast Cancer" (2 trials), "Non-Small Cell Lung Cancer" (2 trials), "Non-small Cell Lung Cancer (NSCLC)" (2 trials) and "Advanced Gastric Cancer" (1 trials). Many other conditions were trialed in "Tuen Mun Hospital; Clinical Oncology" in a lesser frequency.

Most popular intervention types in "Tuen Mun Hospital; Clinical Oncology" are "Drug" (16 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Trastuzumab" (3 trials), "Capecitabine" (2 trials), "Paclitaxel" (2 trials) and "Pertuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tuen Mun Hospital; Clinical Oncology" are 14 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Tuen Mun Hospital; Clinical Oncology". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Tuen Mun Hospital; Clinical Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tuen Mun Hospital; Clinical Oncology, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".